EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a ...
Cancer immunotherapy transforms a patient’s immune cells into a “search‑and‑destroy” force against tumors. But many cancers learn to camouflage themselves from dendritic cells—the immune system’s ...
The identification of TAAs over the last decade has led to great interest in developing cancer immunotherapies that result in strong cytotoxic T-lymphocyte (CTL) responses directed to them. The most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback